Harvoni

The Most Expensive Drugs of 2016
Motley Fool
Mon, 12/19/16 - 11:32 am
drug pricing
Gilead Sciences
Harvoni
Sovaldi
H.P. Acthar
Mallinckrodt
Shire
Cinryze
Daklinza
Bristol-Myers Squibb
Gilead’s Patent Loss to Merck Started With a Broken Friendship
Bloomberg
Mon, 12/19/16 - 10:55 am
Gilead Sciences
Merck
patents
hepatitis C
Sovaldi
Harvoni
Merck Wins Record $2.5 Billion Patent Verdict Against Gilead
Bloomberg
Fri, 12/16/16 - 09:51 am
Merck
patents
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Motley Fool
Sun, 11/20/16 - 05:37 pm
Medicare
H.P. Acthar Gel
Mallinckrodt
Remodulin
United Therapeutics
Tyvaso
Provenge
Valeant Pharmaceuticals
Gilead Sciences
Harvoni
Gilead hepatitis C pill was biggest 2015 drug cost for Medicare, Medicaid
Stat/Pharmalot
Tue, 11/15/16 - 09:24 am
Gilead Sciences
hepatitis C
Medicare
Medicaid
Harvoni
Unfazed by FDA Warning, Gilead Sciences' Stock Could Be Turning a Corner
Motley Fool
Sat, 10/29/16 - 01:19 pm
FDA
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
How Gilead Dominates the HCV Space
Market Realist
Mon, 09/26/16 - 09:50 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead Sciences: Are Hepatitis C Sales Getting Better?
Barron's
Fri, 09/23/16 - 10:13 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead to get attorney fees in hepatitis C patent fight with Merck
Yahoo/Reuters
Thu, 08/11/16 - 11:35 pm
Gilead Sciences
Merck
hepatitis C
Sovaldi
Harvoni
As hep C sales decline, Wall Street wonders what Gilead does for its next act
Stat
Wed, 07/27/16 - 09:49 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
3 Potential Stock-Moving Drug Events In The Second Half Of 2016
Investors.com
Fri, 07/1/16 - 10:07 am
Eli Lilly
solanezumab
Alzheimer's disease
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Epclusa
Sanofi
Regeneron
Praluent
Gilead Sciences, Inc: Uptick in New HCV Scripts Does Not Signal a Good Quarter
Bidness, ETC
Sat, 06/18/16 - 09:18 am
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
Gilead Sciences: A ‘Strong Uptick’ in New Hepatitis C Prescriptions
Barron's
Fri, 06/17/16 - 12:16 pm
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Will Gilead (GILD) Stock Be Helped by Hepatitis C Drug Patents Case Win?
TheStreet.com
Thu, 06/9/16 - 09:47 am
Gilead Sciences
Merck
patents
hepatitis C
Harvoni
Sovaldi
Gilead won’t have to pay $200 million in patent case because Merck lawyer lied
Stat
Wed, 06/8/16 - 09:38 am
Gilead Sciences
patents
Merck
hepatitis C
Sovaldi
Harvoni
Washington Ordered to Cover Hepatitis C Drugs During Lawsuit
Bloomberg
Fri, 05/27/16 - 10:54 pm
hepatitis C
Washington
Medicaid
Harvoni
Sovaldi
Gilead Sciences
Gilead Sciences’ Big Growth Opportunity for 2016 Is HCV
Yahoo/Market Realist
Thu, 05/19/16 - 09:41 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Behind Gilead Sciences’ Pricing Pressures for HCV Drugs in the US
Yahoo/Market Realist
Thu, 05/12/16 - 09:47 am
Gilead Sciences
hepatitis C
drug pricing
Harvoni
Sovaldi
Gilead Judge Re-Opens Case Amid Claim Merck Scientist Lied
Bloomberg
Sat, 04/30/16 - 10:41 am
Gilead Sciences
Merck
hepatitis C
Harvoni
Sovaldi
Seven New York insurers end restrictions on coverage for hepatitis C drugs
BioPharma Dive
Wed, 04/27/16 - 09:20 am
New York
insurers
hepatitis C
Merck
Zepatier
Gilead Sciences
Harvoni

Pages